menu search

Prime medicine reports third quarter 2023 financial results and provides business updates

— Presented new preclinical research across multiple programs, including proof-of-concept data from in vivo rodent and large animal ...

November 3, 2023, 8:01 pm

Cellectis: end of 2023 data readouts to boost car-t prospects

Preliminary data from two early-stage studies are going to be shown at the ASH 2023 conference, showcas...

November 3, 2023, 6:57 pm

European investment bank backs dutch agritech innovator in-ovo with €40m loan

studies indicate roughly 6.5 billion male chicks are killed annually. Globally, this practice ruffles t...

November 3, 2023, 9:41 am

Vincerx pharma to present three posters at ash 2023 in december

VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...

November 2, 2023, 9:10 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

S&p 500 bound for deeper waters?

Technical studies demonstrate room for further selling on the S&P 500. The post S&P 500 Bound for Deepe...

October 26, 2023, 5:38 pm

Comparing dcbs in de novo cad: drugs, design matter

At TCT 2023, two studies of sirolimus- vs paclitaxel-coated devices reached different conclusions about...

October 25, 2023, 10:16 pm

Eight things you need to know about student loans and finance

For undergraduates who live in England and started their studies this year, there are big changes to ho...

October 25, 2023, 10:59 am

Safety concerns in med spas with little to no physician involvement

Recent studies Demonstrate the Importance of Regulating Medical Spas to Protect Patient Schaumburg, IL,...

October 19, 2023, 3:17 pm

Gbp/usd: break of pivotal supports risks further weakness

Fresh leg lower extends into third straight day, with increasing downside risk seen after break of pivotal supports at 1.2170/22 (trendline support / ...

October 19, 2023, 10:05 am

Sage therapeutics: several neuropsychiatric disorder data readouts in 2024

Sage Therapeutics, Inc. received FDA approval along with Biogen for its drug ZURZUVAE for the treatment of postpartum depression, with a planned launc...

October 18, 2023, 6:52 pm

Sage therapeutics jump 5% on huntington's drug call by fda

Shares of Sage Therapeutics Inc jumped 5% in premarket trading following the announcement that the US Food and Drug Administration (FDA) has granted...

October 18, 2023, 7:41 am

Glencore to close historic mt isa copper operation in australia

Glencore PLC (LSE:GLEN) has announced the closure of its copper mines in Mt Isa, Queensland, by 2025, affecting 1,200 workers and ending 60 years of ...

October 18, 2023, 6:04 am

Predicine announces six studies showcasing mrd and liquid biopsy innovations at esmo 2023

HAYWARD, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) — Predicine, a pioneer in the liquid biopsy, announce its participation in the European Society for ...

October 17, 2023, 5:58 pm

Iphone 15 sales start off slow in china

Sales of Apple's new iPhone 15 in China are down 4.5% compared with the iPhone 14 over their first 17 days after release, according separate ...

October 16, 2023, 12:45 pm

Eur/usd: significant gains will be hard to come by at the moment – scotiabank

Modest gains for the EUR on the session so far are mildly positive from a technical point of view but the EUR is battling against a tide of bearish mo...

October 16, 2023, 12:14 pm

Nanoviricides updates investors on phase 1a/1b trial of antiviral drug candidate for coronavirus

NanoViricides (NYSE-A:NNVC) said it has sufficient funds to complete its ongoing Phase 1a/1b clinical trial of its lead drug candidate NV-CoV-2 based ...

October 16, 2023, 9:13 am


Search within

Pages Search Results: